Patten & Patten Inc Bristol Myers Squibb CO Transaction History

Patten & Patten Inc

  • $1.42 Billion
  • Q1 2025

A detailed history of Patten & Patten Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Patten & Patten Inc holds 68,319 shares of BMY stock, worth $3.41 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
68,319
Previous 71,551 4.52%
Holding current value
$3.41 Million
Previous $4.05 Million 2.97%
% of portfolio
0.29%
Previous 0.28%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 07, 2025
SELL
$53.9 - $63.11 $174,204 - $203,971
-3,232 Reduced 4.52%
68,319 $4.17 Million
Q4 2024

Feb 10, 2025
SELL
$51.92 - $59.94 $349,317 - $403,276
-6,728 Reduced 8.59%
71,551 $4.05 Million
Q3 2024

Nov 04, 2024
SELL
$39.66 - $51.75 $58,220 - $75,969
-1,468 Reduced 1.84%
78,279 $4.05 Million
Q2 2024

Aug 13, 2024
SELL
$40.25 - $52.99 $363,457 - $478,499
-9,030 Reduced 10.17%
79,747 $3.31 Million
Q1 2024

May 10, 2024
BUY
$47.98 - $54.4 $195,134 - $221,244
4,067 Added 4.8%
88,777 $4.81 Million
Q4 2023

Jan 23, 2024
SELL
$48.48 - $57.85 $888,008 - $1.06 Million
-18,317 Reduced 17.78%
84,710 $4.35 Million
Q3 2023

Oct 27, 2023
SELL
$57.89 - $64.73 $421,612 - $471,428
-7,283 Reduced 6.6%
103,027 $5.98 Million
Q2 2023

Jul 14, 2023
BUY
$63.71 - $70.74 $275,418 - $305,809
4,323 Added 4.08%
110,310 $7.05 Million
Q1 2023

Apr 25, 2023
BUY
$65.71 - $74.53 $20,567 - $23,327
313 Added 0.3%
105,987 $7.35 Million
Q4 2022

Feb 01, 2023
SELL
$68.48 - $81.09 $239,269 - $283,328
-3,494 Reduced 3.2%
105,674 $7.6 Million
Q3 2022

Oct 19, 2022
SELL
$0.13 - $76.84 $136 - $80,682
-1,050 Reduced 0.95%
109,168 $7.76 Million
Q2 2022

Aug 02, 2022
BUY
$72.62 - $79.98 $126,939 - $139,805
1,748 Added 1.61%
110,218 $8.49 Million
Q1 2022

Apr 25, 2022
BUY
$61.48 - $73.72 $214,688 - $257,430
3,492 Added 3.33%
108,470 $7.92 Million
Q4 2021

Jan 26, 2022
BUY
$53.63 - $62.52 $381,791 - $445,079
7,119 Added 7.27%
104,978 $6.55 Million
Q3 2021

Oct 22, 2021
BUY
$59.17 - $69.31 $144,611 - $169,393
2,444 Added 2.56%
97,859 $5.79 Million
Q2 2021

Jul 13, 2021
BUY
$61.91 - $67.42 $151,989 - $165,516
2,455 Added 2.64%
95,415 $6.38 Million
Q1 2021

Apr 23, 2021
BUY
$59.34 - $66.74 $108,829 - $122,401
1,834 Added 2.01%
92,960 $5.87 Million
Q4 2020

Jan 19, 2021
BUY
$57.74 - $65.43 $300,363 - $340,366
5,202 Added 6.05%
91,126 $5.65 Million
Q3 2020

Oct 08, 2020
BUY
$57.43 - $63.64 $322,814 - $357,720
5,621 Added 7.0%
85,924 $5.18 Million
Q2 2020

Jul 21, 2020
BUY
$54.82 - $64.09 $1.8 Million - $2.1 Million
32,776 Added 68.96%
80,303 $4.72 Million
Q1 2020

Apr 16, 2020
BUY
$46.4 - $67.43 $208,753 - $303,367
4,499 Added 10.46%
47,527 $2.65 Million
Q4 2019

Jan 13, 2020
BUY
$49.21 - $64.19 $118,300 - $154,312
2,404 Added 5.92%
43,028 $2.76 Million
Q3 2019

Oct 15, 2019
SELL
$42.77 - $50.71 $21,513 - $25,507
-503 Reduced 1.22%
40,624 $2.06 Million
Q2 2019

Jul 11, 2019
SELL
$44.62 - $49.34 $346,697 - $383,371
-7,770 Reduced 15.89%
41,127 $1.87 Million
Q1 2019

Apr 23, 2019
SELL
$45.12 - $53.8 $29,012 - $34,593
-643 Reduced 1.3%
48,897 $2.33 Million
Q4 2018

Jan 17, 2019
SELL
$48.76 - $63.23 $6.26 Million - $8.12 Million
-128,472 Reduced 72.17%
49,540 $2.58 Million
Q3 2018

Oct 17, 2018
BUY
$55.19 - $62.25 $27,926 - $31,498
506 Added 0.29%
178,012 $11.1 Million
Q2 2018

Jul 18, 2018
SELL
$50.53 - $62.98 $223,544 - $278,623
-4,424 Reduced 2.43%
177,506 $9.82 Million
Q1 2018

Apr 20, 2018
BUY
$59.92 - $68.98 $306,550 - $352,901
5,116 Added 2.89%
181,930 $11.5 Million
Q4 2017

Jan 22, 2018
BUY
$59.94 - $65.35 $554,504 - $604,552
9,251 Added 5.52%
176,814 $10.8 Million
Q3 2017

Oct 12, 2017
BUY
$55.23 - $63.74 $9.25 Million - $10.7 Million
167,563
167,563 $10.7 Million

Others Institutions Holding BMY

# of Institutions
2,811
Shares Held
1.59B
Call Options Held
25.9M
Put Options Held
23.9M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $106B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Patten & Patten Inc Portfolio

Follow Patten & Patten Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patten & Patten Inc, based on Form 13F filings with the SEC.

News

Stay updated on Patten & Patten Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email